Equities researchers at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued on Tuesday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Trading Up 2.3 %
Shares of MDRX stock opened at $10.79 on Tuesday. Veradigm has a 1 year low of $5.01 and a 1 year high of $12.66. The firm’s 50 day moving average is $9.82 and its 200-day moving average is $9.60.
Hedge Funds Weigh In On Veradigm
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC acquired a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- There Are Different Types of Stock To Invest In
- Tesla Poised to Hit Record Highs This Holiday Season
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- The Salesforce Rally is Just Getting Started: Here’s Why
- What is the S&P/TSX Index?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
